Related Experiment Video

Updated: Jul 18, 2026

Using RNA-interference to Investigate the Innate Immune Response in Mouse Macrophages
12:47

Using RNA-interference to Investigate the Innate Immune Response in Mouse Macrophages

Published on: November 3, 2014

Induction of interleukins IL-6 and IL-8 by siRNA

E Pauls1, J Senserrich, M Bofill

  • 1Retrovirology Laboratory irsiCaixa, Hospital Universitari Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona, Spain.

Clinical and Experimental Immunology
|December 21, 2006
PubMed

Insights

Small interfering RNA (siRNA) targeting CCR5 effectively reduced HIV-1 replication and syncytia formation. However, some siRNA agents also triggered non-specific innate immune responses, indicated by interleukin-6 and interleukin-8 production.

Area of Science:

  • Immunology
  • Virology
  • RNA Therapeutics

Background:

  • The C-C chemokine receptor type 5 (CCR5) is a crucial co-receptor for Human Immunodeficiency Virus type 1 (HIV-1) entry.
  • Small interfering RNA (siRNA) has emerged as a potential therapeutic strategy targeting CCR5 to inhibit HIV-1 infection.

Purpose of the Study:

  • To evaluate the efficacy of CCR5-targeting siRNA in inhibiting HIV-1 replication.
  • To investigate whether siRNA agents can induce innate cytokine responses.

Main Methods:

  • siRNA agents were tested for their ability to down-regulate CCR5 expression.
  • HIV-1 replication, syncytia formation, and infection of CD4+ cells were measured.
  • Cytokine production (IL-6, IL-8, interferons, TNF-alpha, etc.) was assessed following siRNA treatment.

Main Results:

  • All tested siRNA agents successfully down-regulated CCR5 expression (51-74%) and inhibited HIV-1 infection (46-83%).
  • siRNA targeting CCR5 specifically inhibited HIV-1 replication, not a VSV-pseudotyped virus.
  • Two of four siRNA agents induced significant production of interleukin-6 (sixfold) and interleukin-8 (ninefold), without inducing other tested cytokines like interferons.

Conclusions:

  • CCR5-targeting siRNA demonstrates potent antiviral activity against HIV-1.
  • Certain siRNA agents can elicit non-specific innate immune responses, evidenced by IL-6 and IL-8 induction, which warrants consideration in therapeutic development.

More Related Videos

Using an Automated Cell Counter to Simplify Gene Expression Studies: siRNA Knockdown of IL-4 Dependent Gene Expression in Namalwa Cells10:34

Using an Automated Cell Counter to Simplify Gene Expression Studies: siRNA Knockdown of IL-4 Dependent Gene Expression in Namalwa Cells

Published on: April 14, 2010

Highly Efficient Transfection of Human THP-1 Macrophages by Nucleofection07:54

Highly Efficient Transfection of Human THP-1 Macrophages by Nucleofection

Published on: September 2, 2014

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...